Science. Hope. Solutions.
Innovative Testing, Personalized Solutions.
Revolutionizing Patient Care through Innovative Diagnostics
- Neurology
- Cardiovascular
- Oncology
Neurodevelopmental, Neuropsychiatric and Neurodegenerative Disorders
ReligenDX is dedicated to advancing the understanding and treatment of neurodevelopmental, neuropsychiatric and neurodegenerative disorders through innovative diagnostic testing. Our comprehensive suite of tests, including FRAT®, MitoSwabTM, provide valuable insights into the underlying genetic and metabolic factors contributing to neurodevelopmental, neuropsychiatric and neurodegenerative conditions.
Cardiovascular Health
Our cutting-edge CholEffluXTM test analyzes HDL function, providing a comprehensive assessment of cardio vascular risk factors. By identifying impairments in cholesterol efflux capacity, healthcare providers can develop targeted interventions to improve cardio vascular health outcomes.
Cancer Care
ReligenDX is committed to advancing cancer diagnostics and personalized treatment strategies. Our state-of-the-art genetic testing solutions, such as sTRA, CA 19-9, help identify key biomarkers and genetic variations that can lead to targeted therapies and improve patient outcomes.
Latest Statistics and Research
16%
Children in the United States were diagnosed with a Developmental Disability
1/36
1 in 36 Children in the United States have been identified with ASD
48.5%
American adults that have Heart or Blood Vessel Disease
What do these statistics have to do with ReligenDX?
Our testing directly addresses researched diagnosis of these conditions on a cellular and molecular level. Testing at these levels allows for individualized results and treatments, leading physicians and patients towards optimal personalized health.
Blog
Order a Test Kit
Lab Address
5110 Campus Drive, Suite #120
Plymouth Meeting, PA
19462